Literature DB >> 33284429

ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer.

H H Wang1,2, J Th M Plukker1, G A P Hospers3.   

Abstract

Entities:  

Year:  2020        PMID： 33284429     DOI： 10.1245/s10434-020-09438-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

2.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Authors:  Joel Shapiro; J Jan B van Lanschot; Maarten C C M Hulshof; Pieter van Hagen; Mark I van Berge Henegouwen; Bas P L Wijnhoven; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W Ten Kate; Geert-Jan M Creemers; Cornelis J A Punt; John Th M Plukker; Henk M W Verheul; Ernst J Spillenaar Bilgen; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus; Ewout W Steyerberg; Ate van der Gaast
Journal:  Lancet Oncol       Date:  2015-08-05       Impact factor: 41.316

3.  ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer.

Authors:  H H Wang; J Th M Plukker; G A P Hospers
Journal:  Ann Surg Oncol       Date:  2020-12-07       Impact factor: 5.344

4.  A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.

Authors:  Tessa Kennedy-Martin; Sarah Curtis; Douglas Faries; Susan Robinson; Joseph Johnston
Journal:  Trials       Date:  2015-11-03       Impact factor: 2.279
  4 in total
  5 in total

1.  ASO Author Reflections: Preoperative Assessment of Remnant Liver Function.

Authors:  Yajie Wang; Lin Zhang; Jiahong Dong; Huijun Chen
Journal:  Ann Surg Oncol       Date:  2020-11-17       Impact factor: 5.344

2.  Effect of Postoperative Oral Intake Status on Sarcopenia Six Months After Esophageal Cancer Surgery.

Authors:  Nanako Hijikata; Aiko Ishikawa; Satoru Matsuda; Michiyuki Kawakami; Kaori Muraoka; Makiko Ando; Shuhei Mayanagi; Tomoyuki Irino; Hirofumi Kawakubo; Yuko Kitagawa; Tetsuya Tsuji
Journal:  Dysphagia       Date:  2022-06-18       Impact factor: 3.438

3.  The long-term outcomes of laparoscopic versus open pancreatoduodenectomy for ampullary carcinoma showed similar survival: a case-matched comparative study.

Authors:  Jeanne Dembinski; Tomoaki Yoh; Béatrice Aussilhou; Fadhel Samir Ftériche; Cornélia P A Hounkonnou; Olivia Hentic; Jérome Cros; Alain Sauvanet; Safi Dokmak
Journal:  Surg Endosc       Date:  2021-11-01       Impact factor: 3.453

4.  The outcome of laparoscopic pancreatoduodenectomy is improved with patient selection and the learning curve.

Authors:  Safi Dokmak; Béatrice Aussilhou; Fadhel Samir Ftériche; Jeanne Dembinski; Chihebeddine Romdhani; Alain Sauvanet
Journal:  Surg Endosc       Date:  2021-04-21       Impact factor: 4.584

5.  ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer.

Authors:  H H Wang; J Th M Plukker; G A P Hospers
Journal:  Ann Surg Oncol       Date:  2020-12-07       Impact factor: 5.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.